EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 273 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $376,000 | +17.1% | 7,196 | +8.4% | 0.01% | +14.3% |
| Q2 2019 | $321,000 | -3.0% | 6,636 | +1.3% | 0.01% | 0.0% |
| Q1 2019 | $331,000 | -14.7% | 6,552 | 0.0% | 0.01% | -22.2% |
| Q4 2018 | $388,000 | -9.6% | 6,552 | +0.4% | 0.01% | 0.0% |
| Q3 2018 | $429,000 | +30.8% | 6,524 | +0.4% | 0.01% | +28.6% |
| Q2 2018 | $328,000 | -4.1% | 6,496 | 0.0% | 0.01% | -12.5% |
| Q1 2018 | $342,000 | +29.5% | 6,496 | +14.3% | 0.01% | +33.3% |
| Q4 2017 | $264,000 | +38.9% | 5,684 | +20.8% | 0.01% | +20.0% |
| Q3 2017 | $190,000 | +65.2% | 4,704 | +38.8% | 0.01% | +66.7% |
| Q2 2017 | $115,000 | +134.7% | 3,388 | +101.7% | 0.00% | +200.0% |
| Q1 2017 | $49,000 | -55.0% | 1,680 | -49.2% | 0.00% | -66.7% |
| Q4 2016 | $109,000 | – | 3,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIMZ Investment Advisors, LLC | 52,590 | $621 | 0.29% |
| Values First Advisors, Inc. | 33,942 | $400,858 | 0.28% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 91,000 | $1,075,000 | 0.23% |
| SummerHaven Investment Management, LLC | 25,347 | $299,348 | 0.18% |
| PALISADE CAPITAL MANAGEMENT, LP | 501,672 | $5,924,746 | 0.16% |
| CORNERCAP INVESTMENT COUNSEL INC | 67,457 | $796,667 | 0.14% |
| Edgestream Partners, L.P. | 94,553 | $1,116,671 | 0.13% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 86,569 | $1,022,380 | 0.12% |
| DUALITY ADVISERS, LP | 77,298 | $912,889 | 0.10% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,253,042 | $14,798,427 | 0.10% |